HELIX
NootropicAnti-Aging

Pinealon

Also known as EDR peptide, Glu-Asp-Arg

Pinealon is a short tripeptide (Glu-Asp-Arg) developed in Russia alongside Epithalon. It penetrates the blood-brain barrier and acts as a DNA-targeting neuroprotective agent, shown to extend lifespan and protect neurons in aged animals.

Typical dosing
500–2000 mcg · Once daily
Administration
SubQ, intranasal, oral (some debate on absorption)
Half-life
Unknown
Level
intermediate

How it works

Short peptide that penetrates cell membranes and the BBB. Binds chromatin in neurons, regulating DNA transcription. Increases tyrosine hydroxylase and tryptophan hydroxylase expression, boosting catecholamine synthesis.

Benefits

  • Penetrates blood-brain barrier directly
  • Neuroprotective — reduces neuronal death
  • Normalizes serotonin and dopamine synthesis in aging brain
  • Geroprotective — shown to extend lifespan in animal models
  • DNA repair and protection in neurons
  • Improves cognitive function in aging

Dosing

500–2000 mcg · Once daily

Course-based: 10 days on, months off. Can be taken SubQ or intranasally.

Ranges reflect commonly cited research protocols, not a prescription. Dose with a licensed provider.

Reconstitution

Standard reconstitution

Helix’s free reconstitution calculator gives you the exact draw volume → get the app

Common stacks

Reported side effects

  • Very limited data
  • Generally well tolerated

Who it’s for

Those focused on neuroprotection and cognitive aging. Often combined with Epithalon in Russian longevity protocols.

Track Pinealon in Helix

Dose reminders, reconstitution math, vial tracking, and AI guidance — free on iOS.

Download free

RELATED COMPOUNDS